AusMed Innovations Urine Drug Test 6-Panel Cup

Key Features

• 6-panel simultaneous urine drug screening
• Screens for AMP, BZO, COC, THC, MET and MOP/OPI
• Integrated creatinine check for specimen integrity
• Rapid chromatographic immunoassay
• No instrument or reader required
• Built-in procedural control
• Easy-to-read visual results
• Suitable for point-of-collection screening
• Test cup format simplifies specimen collection and testing
• Can be used in accordance with AS/NZS 4308:2023
• Intended for in vitro diagnostic use
• Store at 2–30°C
• Individually sealed test cup

Product: AusMed Innovations Multi-Drug Rapid Test Cup
Configuration: 6-panel
Specimen: Human urine
Test Type: Rapid chromatographic immunoassay
Drug Panels: AMP / BZO / COC / THC / MET / MOP/OPI
Creatinine Check: Yes
AMP Cut-Off: 300 ng/mL
BZO Cut-Off: 200 ng/mL
COC Cut-Off: 150 ng/mL
THC Cut-Off: 50 ng/mL
MET Cut-Off: 300 ng/mL
MOP/OPI Cut-Off: 300 ng/mL
Result Type: Qualitative preliminary screening
Storage: 2–30°C
Freezing: Do not freeze
Intended Use: In vitro diagnostic use by healthcare professionals and appropriately trained drug-testing personnel

The AusMed Innovations Multi-Drug Rapid Test Cup is intended to provide a preliminary qualitative screening result. Non-negative results should be confirmed using an appropriate laboratory confirmation method such as LC-MS/MS or GC-MS, with confirmation performed by a NATA-accredited laboratory where applicable.

A non-negative screening result does not indicate a level of intoxication or impairment. Negative results indicate that the concentration is below the applicable screening cut-off and do not necessarily mean that the drug or metabolite is completely absent.

Testing should be performed by appropriately trained personnel and in accordance with applicable procedures and AS/NZS 4308:2023.